DIRS.INFO The most relevant business & tech news

☆ This rare muscle disease play can rally more than 50%, BofA says
▼ + stars: | 2024-05-03 | by ( Alex Harring | ) www.cnbc.com time to read: +2 min

Avidity Biosciences stock has more room to run thanks to the company's pipeline of multiple treatments for rare muscle disorders, according to Bank of America. Avidity has a therapeutic platform — antibody oligonucleotide conjugates — that was well-received at the time it went public in 2020, Meacham said. But shares were hurt by a clinical hold on Avidity's leading program for treating an uncommon muscle disorder, DM1. The program, tested in the Marina trial, recently saw long-term data that has "helped lift that key overhang on the stock," Meacham said. Those catalysts are tied to two other drugs in the muscle disorder space that are expected to report data this year, according to Meacham.

Persons: Geoff Meacham, Meacham Organizations: Biosciences, Bank of America Locations: San Diego, Thursday's

☆ The CEO of a weight-loss ETF that's crushing the S&P 500 since launching in November shares 4 stocks he sees with over 100% upside in the next 12 months
▼ + stars: | 2024-04-04 | by ( William Edwards | ) www.businessinsider.com time to read: +5 min

Weight-loss drugs like Ozempic, Wegovy, and Mounjaro are all the rage, and investors are noticing. Since launching in November, the Tema Obesity and Cardiometabolic ETF (HRTS) is up 24%, crushing the S&P 500's 14.8% returns over the same period. Pot and his colleagues at Tema are bullish on the weight-loss drug stocks due to the wave of demand they see coming. Novo Nordisk estimates that only 2% of obesity cases are being treated by weight-loss drugs, Pot said. 4 weight-loss drug stocks to watchPot listed two larger stocks and two smaller ones in the space.

Persons: Maurits Pot, Janus Henderson, Pot, Goldman Sachs, Geoff Meacham, Charles Barkley, Elon Musk, Whoopi Goldberg, Eli Lilly, Lilly Organizations: VanEck Pharmaceutical, Business, World Health Organization, Novo Nordisk, Bank of America, Bank, Nordisk, FDA, Amazon, Therapeutics, Zealand Pharma Locations: Tema, GLP, Danish, it's

☆ Viking stock doubled Tuesday. Here's where the next moves in the obesity space could come from
▼ + stars: | 2024-02-27 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

VKTX YTD mountain Viking shares year to date Then, Viking shares more than doubled in trading on Tuesday, putting the stock on pace to report a more than 300% year-to-date gain, after the company said its GLP-1/GIP receptor agonist VK2735 hit all its primary goals in a phase 2 clinical trial. The Tema Cardiovascular and Metabolic ETF (HRTS) , which is up 12% year to date, owns Novo, Lilly and Viking. Still early days Some analysts and investors admit it is still very early days for obesity treatment and many questions remain to be answered. "We continue to expect above consensus growth in the space, as we are bullish on adoption from payers and broader obesity uptake," Meacham wrote. For obesity only, Lilly has already gained a 38% share, despite only being in the market for 13 weeks, he said.

Persons: Eli Lilly, Geoff Meacham, Meacham, Lilly, Yuri Khodjamirian, Khodjamirian, Jeff Jonas, Becton Dickinson, Novo, BofA's Meacham, What's, Tema's, it's, Gabelli's Jonas, he's, William Blair, Andy Hsieh, Hsieh Organizations: Novo Nordisk, Bank of America, Centers for Disease Control, Zealand Pharma, Viking Therapeutics, Zealand, Food and Drug Administration, Novo, Metabolic, Therapeutics, Pharmaceuticals, Rock, AstraZeneca, Roche, Gabelli Funds, FDA, Viking, Merck, Pfizer Locations: U.S, Tema, Novo Nordisk's, GLP, Lilly

☆ Medtronic CEO on earnings: Back to growth in China after challenging few years
▼ + stars: | 2024-02-20 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMedtronic CEO on earnings: Back to growth in China after challenging few yearsGeoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.

Persons: Geoff Martha, Martha Locations: China

DES MOINES, Iowa (AP) — Iowa’s medical board on Thursday approved some guidance abortion providers would need to follow if the state’s ban on most abortions after about six weeks of pregnancy is upheld by the Iowa Supreme Court. The restrictive abortion law is currently on hold as the court considers Gov. That would be a stark change for women in Iowa, where abortion is legal up to 20 weeks of pregnancy. Most Republican-led states have drastically limited abortion access since the U.S. Supreme Court overturned Roe v. Wade and handed authority on abortion law to the states. Fourteen states now have bans with limited exceptions and two states, Georgia and South Carolina, ban abortion after cardiac activity is detected.

Persons: —, Kim Reynolds, ”, Roe, Wade, Geoff Mulvihill Organizations: DES, Iowa Supreme, Republican, Texas Supreme, Supreme, Associated Press Locations: DES MOINES, Iowa, Texas, U.S, Georgia, South Carolina, Cherry Hill , New Jersey

The problem underscores a widely held consensus that Virginia’s mental health care system is in urgent need of reform, due to what Gov. Improving mental health care became a priority in the U.S. like never before as the pandemic brought new levels of isolation, fear and grief, in addition to pre-existing crises such as rising drug overdose deaths and the struggles burdening teen girls. Survey data from the U.S. Substance Abuse and Mental Health Services Administration found that in 2022, about half of adults with any mental illness did not receive treatment. Elsewhere in the U.S., states' policy concerns and approaches to improving mental health care have varied. Mental health was listed as a budget priority in most states in an analysis by the National Association of State Budget Officers.

Persons: — John Clair, Clair, ”, Glenn Youngkin’s, Virginia’s, we’ve, Brian Hepburn, —, John Littel, ” Littel, Youngkin, they're, it’s, Katherine McGuire, candor, he's, “, ____ Geoff Mulvihill Organizations: Clair's, Marion Police Department crisscross, Marion, Army, Gov, Republican, Mental Health Services Administration, National Association of State Mental Health, National Association of State, American Psychological Association, “, Assembly Locations: RICHMOND, Va, Virginia, U.S, Cherry Hill , New Jersey

☆ Human bones unearthed from a German cave have altered the timeline of ancient human history
▼ + stars: | 2024-02-12 | by ( Ellyn Lapointe | ) www.businessinsider.com time to read: +7 min

This led them to Ilsenhöhle cave in Ranis, Germany, one of several sites across Northwestern Europe where LRJ artifacts have been found. AdvertisementMining ancient DNAWhen they excavated the cave, the researchers uncovered more than just LRJ artifacts — they came upon tiny bone fragments, too. AdvertisementTo that end, they extracted DNA, which confirmed the bones belong to Homo sapiens, providing strong evidence that they were responsible for the LRJ artifacts. According to their data, Homo sapiens were present in Ranis 47,500 years ago — thousands of years earlier than previously thought. Geoff M. SmithQuestions remain about how warm-weather-adapted Homo sapiens survived such a dramatic transition.

Persons: —, Josephine Schubert, sapiens, ”, Jean, Jacques Hublin, Hublin, Tim Schüler, Max Planck, ” Hublin, Dorothea Mylopotamitaki, Homo sapiens, Marcel Weiss, “ It’s, sapien, Geoff M, Smith, Geoff Smith, “ Organizations: Service, Business, Burg, College of France, Max, Max Planck Institute, University of Kent Locations: Ranis, Europe, Germany, Northwestern Europe, Western Europe, Africa, Scandinavia, Siberia

☆ BofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesity
▼ + stars: | 2024-02-06 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBofA's Geoff Meacham on Eli Lilly on Q4 results: The story has changed to diabetes and obesityGeoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to discuss the company's quarterly earnings results, which reported fourth-quarter revenue and adjusted earnings that topped expectations on the strong launch of its new weight loss drug, Zepbound, and higher prices for its blockbuster diabetes treatment, Mounjaro.

Persons: Geoff Meacham, Eli Lilly Organizations: Bank of America Securities

☆ These smaller stocks could see big gains in 2024, Bank of America says
▼ + stars: | 2024-01-30 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +5 min

Against this backdrop, Bank of America on Monday released a list of best small- and mid-cap ideas for 2024. Strategist Jill Carey Hall added that this year's basket of 31 stocks has average 12-month potential upside of 29%, and is slightly tilted towards value stocks over growth. Shares of Bath & Body Works have trailed the market, rising 2.4% in 2023 and 0.4% so far in 2024. Bank of America also named United Airlines one of its top SMID ideas for 2024. Other names on Bank of America's list of SMID picks included e-commerce retailer Wayfair and aircraft leasing company Air Lease .

Persons: That's, Russell, Jill Carey Hall, Lorraine Hutchinson, Hutchinson, BofA, Geoff Meacham, Lou Gehrig's, Meacham, CyberArk, Tal Liani, Liani, Max, Andrew Didora, UAL, Didora, — CNBC's Michael Bloom Organizations: Wall, Bank of America, Monday, Body, Pharmaceuticals, TAM, United Airlines, Boeing, Bank of, Air Lease Locations: U.S, Amylyx, cybersecurity, CY26, Chicago

☆ BofA's Geoff Meacham on Pfizer earnings: The story is still about Covid contraction
▼ + stars: | 2024-01-30 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBofA's Geoff Meacham on Pfizer earnings: The story is still about Covid contractionGeoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to break down Pfizer's quarterly earnings results, Big Pharma 2024 outlook, and more.

Persons: Geoff Meacham Organizations: Pfizer, Bank of America Securities, Big Pharma

OLYMPIA, Wash. (AP) — The Washington state attorney general announced a $149.5 million settlement Wednesday with drugmaker Johnson & Johnson, more than four years after the state sued the company over its role fueling the opioid addiction crisis. If approved, the deal would send over $20 million more to respond to the opioid crisis than if the state had signed onto a national settlement in 2021 involving Johnson & Johnson, the attorney general’s office said. Washington state’s Democratic attorney general sued Johnson & Johnson in 2020, alleging that it helped drive the pharmaceutical industry’s expansion of prescription opioids. “The Company’s actions relating to the marketing and promotion of important prescription opioid medications were appropriate and responsible,” according to the statement. The attorney general’s office noted that the company was one of the largest suppliers of the raw narcotic materials needed to produce opioid drugs.

Persons: drugmaker Johnson, Johnson, Bob Ferguson, Democratic Sen, June Robinson, Geoff Mulvihill Organizations: Washington State Department of Health, Johnson, Democratic Locations: The Washington, U.S, Washington, Cherry Hill , New Jersey

☆ Eli Lilly's Zepbound is off to a strong start, but here's what needs to happen to push shares higher
▼ + stars: | 2024-01-24 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +8 min

Lilly's Mounjaro and Zepbound both use tirzepatide as an active ingredient, but Mounjaro is indicated for type 2 diabetes, while Zepbound aids weight loss. A rich valuation LLY 1Y mountain Eli Lilly shares over the past year. But even good news about Zepbound's launch might not be enough to propel Lilly's stock higher. Goldman's Shibutani has a neutral rating on Lilly shares and a price targe of $600, which implies shares could fall nearly 5% from they started the week. He has a buy rating on Lilly shares, and expects the stock could hit $700 over the next 12 months.

Persons: Eli Lilly's, Lilly, Goldman Sachs, Chris Shibutani, IQVIA, Shibutani, Lilly's, Mounjaro, Eli Lilly, Geoff Meacham, NASH, Meacham, there's, Morgan Stanley, Terence Flynn, Flynn, Morgan Stanley's, Michael Bloom Organizations: Food and Drug Administration, Zepbound, Novo Nordisk's, Medicare, Bank of America, Novo Nordisk, Bank of, FDA, CNBC Locations: Indianapolis, Mounjaro

☆ Where to invest $50,000 with Treasury yields rising again
▼ + stars: | 2024-01-16 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +8 min

The 10-year Treasury yield started the new year trading around 3.8% after a steep decline in late 2023. Against this backdrop, CNBC Pro asked three strategists and money managers how they would allocate $50,000 with yields rising again. Specifically, he recommended bills with a three- to six-month maturity, which investors can gain exposure to through exchange-traded funds such as the Vanguard Short-Term Treasury ETF (VGSH) or SPDR Portfolio Short Term Treasury ETF (SPTS) . Exchange-traded funds that offer exposure to these assets include the iShares 20 Plus Year Treasury Bond ETF (TLT) and Vanguard Intermediate-Term Corporate Bond ETF (VCIT) . Invest in dividend-growing value stocks Newton Investment Management's John Bailer recommended investors solely allocate into value stocks with sustainable and growing dividends.

Persons: Kumar, VGSH, VCIT, John Bailer, JPMorgan Chase, They've, they've, Bailer, Northrop Grumman, James Abate, Abate, Johnson, Geoff Martha, Colgate's Organizations: Treasury, Nasdaq, Dow Jones, CNBC Pro, Sri, Kumar, CNBC, AAA, Exchange, Treasury Bond ETF, Vanguard, Stock Market, U.S, Bloomberg, Newton Investment, JPMorgan Chase, JPMorgan, Northrop, Asset Management, Johnson, Colgate, Palmolive Locations: Bailer's

☆ The impact of wight-loss drugs to our business 'is negligible', says Medtronic CEO
▼ + stars: | 2023-11-21 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe impact of wight-loss drugs to our business 'is negligible', says Medtronic CEOGeoff Martha, Medtronic CEO, joins 'Closing Bell Overtime' to talk quarterly results, the impact of weight-loss drugs, and more.

Persons: Geoff Martha Locations: wight

Possession of under a gram of heroin, for example, is only subject to a ticket and a maximum fine of $100. Some lawmakers have suggested focusing on criminalizing public drug use rather than possession. Backers of Oregon’s approach say decriminalization isn’t necessarily to blame, as many other states with stricter drug laws have also reported increases in fentanyl deaths. Despite public perception, the law has made some progress by directing $265 million dollars of cannabis tax revenue toward standing up the state’s new addiction treatment infrastructure. Horvick, the pollster, said public support for expanding treatment remains high despite pushback against the law.

Persons: — Oregon's, ”, John Horvick, Sen, Kate Lieber, Tina Kotek, Kotek, Jason Edmiston, Alex Kreit, Lily Morgan, Heather Jefferis, ” Lieber, “, Geoff Mulvihill, ___ Claire Rush Organizations: DHM Research, Democratic, Democratic Gov, Republican, Survey, Northern Kentucky University, Addiction Law, U.S . Centers for Disease Control, Health, Networks, Oregon Council, Behavioral Health, Associated Press, America Statehouse News Initiative, America Locations: PORTLAND, Oregon, Portland, Hermiston, California, Washington, U.S, Portugal, Philadelphia

☆ BofA’S Meacham on what's next for Eli Lilly after FDA approves obesity drug
▼ + stars: | 2023-11-08 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailBofA’S Meacham on what's next for Eli Lilly after FDA approves obesity drugGeoff Meacham, Bank of America, joins 'Fast Money' to talk the FDA's approval of Eli Lilly's obesity drug.

Persons: BofA’S Meacham, Eli Lilly, Geoff Meacham, Eli Organizations: Bank of America Locations: what's

Under North Dakota’s law, health care providers can be charged with a felony for performing gender affirmation surgeries on minors, punishable by up to 10 years’ imprisonment and/or a $20,000 fine. Opponents said such surgeries are not performed on minors in North Dakota, and that the ban on gender-affirming care would harm transgender youth, who are at increased risk for depression, suicide and self-harm. The law exempts minors who were already receiving gender-affirming care, and allows for the treatment of “a minor born with a medically verifiable genetic disorder of sex development." At least 22 states have adopted bans on some or all gender-affirming care for minors since 2021. Meanwhile, at least 13 Democrat-controlled states have new laws or executive orders seeking to protect access to gender-affirming care for minors.

Persons: he'll, ”, Brittany Stewart, Judge Jackson Lofgren, Doug Burgum, Stewart, “, ” Stewart, Joe Quinn, Quinn, Geoff Mulvihill Organizations: N.D, U.S, North, Republican, Republican Gov, Democrat, Associated Press Locations: BISMARCK, North Dakota, Dakota, Alabama , Arkansas, Georgia, Indiana , Kentucky, Montana, Tennessee, Alabama , Kentucky, Cherry Hill , New Jersey

☆ Expect Eli Lilly's momentum to continue, says Bank of America's Geoff Meacham
▼ + stars: | 2023-11-02 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailExpect Eli Lilly's momentum to continue, says Bank of America's Geoff MeachamGeoff Meacham, Bank of America senior pharmaceutical analyst, joins 'The Exchange' to discuss Eli Lilly's performance, the demand outlook for weight loss drugs, and more.

Persons: America's Geoff Meacham Geoff Meacham, Eli Lilly's Organizations: America's, Bank of America

Ballot summaries are used on Missouri ballots to help voters understand sometimes lengthy and complex constitutional amendments and policy changes. “We stand by our language and believe it fairly and accurately reflects the scope and magnitude of each petition,” Ashcroft said in a statement. A measure to ensure abortion access is on the November ballot in Ohio after withstanding legal challenges from opponents. Voters in every state with an abortion-related ballot measure since the U.S. Supreme Court overturned Roe v. Wade in 2022, effectively making abortion access a state-by-state question, have favored the side supported by abortion rights supporters. ——-Associated Press writer Heather Hollingsworth in Mission, Kansas and Geoff Mulvihill in Cherry Hill, New Jersey, contributed to this report.

Persons: ”, State Jay Ashcroft, ” Ashcroft, Andrew Bailey’s, Emily Wales, “, Roe, Wade, Heather Hollingsworth, Geoff Mulvihill Organizations: COLUMBIA, —, Republican, Western, Appeals, State, “, Voters, Supreme, Associated Press, NORC, for Public Affairs Research Locations: Mo, Missouri, Plains, ” Missouri, Ohio, Maryland, New York, Arizona , Florida , Nevada, South Dakota, Iowa , Nebraska, Pennsylvania, Colorado, U.S, Mission , Kansas, Cherry Hill , New Jersey

☆ The best places — and best times — to take a safari
▼ + stars: | 2023-10-25 | by ( Harriet Akinyi | ) www.cnbc.com time to read: +8 min

KenyaFor more than 25 years, professional safari guide Geoff Mayes has taken tourists to the best parks in Africa. Amboseli National Park, a UNESCO World Heritage Site, is known for its massive elephant population and spectacular views of Mount Kilimanjaro. In those three, one can track mountain gorillas in Mgahinga National Park and Bwindi Impenetrable National Park. Another park to consider is the Kidepo Valley National Park, with its sweeping plains and valleys overshadowed by the brooding Mount Morungole. ZimbabweApart from the renowned Hwange National Park, I have also visited Matobo National Park, which has a wide diversity of fauna and plenty of white rhinos.

Persons: I've, revel, Harriet Akinyi, Geoff Mayes, Mara —, Masaai Mara, Mara, you'll, Barack Obama, It's, Luis Davilla, There's, Kruger, Addo, Nogaya, Jason Edwards, Dennis Kahungu, Christopher Kidd, Photodisc, Weaver, Clair, Nxai, Patrick J, Cecil Rhodes, Westend61 Organizations: Mara, Reserve, Kenya —, UNESCO, Heritage, Netflix, National Parks, Kruger, Park, Photodisc, Uganda Wildlife Authority, Queen Elizabeth, Lake, CNBC Travel, Getty, Nature, Kalahari Game Reserve, Kenya, Tourists Locations: Africa, Mugie Conservancy, Kenya, Tanzania, South Africa, Uganda, Mozambique, Botswana, Zambia, Zimbabwe, Malawi, Namibia, Rwanda, Nairobi, Mount Kilimanjaro, Solio Conservancy, Africa Kenya, Johannesburg, iMfolozi, Addo, Uganda Uganda, Kyambura, Lake Mburo, Mburo, Ihema, Inti St, Botswana Botswana, Okavango, Matobo

☆ Buy this 'game-changer' biotech stock with more than 50% upside, BofA says
▼ + stars: | 2023-10-10 | by ( Lisa Kailai Han | ) www.cnbc.com time to read: +1 min

Analyst Geoff Meacham's $18 price objective implies a potential upside of 51% from the stock's $11.94 closing price Monday. Meacham cited the firm's strong pipeline of novel drugs and treatments as a catalyst. Specifically, Neumora's navacaprant drug could be a "game-changer for major depressive disorder," Meacham said. "Overall, the diverse pipeline and targets provide multiple opportunities for Neumora to potentially become one of the largest neuro-focused biotech companies." While the company is currently unprofitable, Meacham expects this to change in 2027, or one year after the company officially commercializes navacaprant for major depressive disorders.

Persons: Geoff Meacham's, Meacham, — CNBC's Michael Bloom Organizations: Bank of America

☆ These are the food and snack companies most at risk as the new obesity drugs revolutionize consumer behavior, according to BofA
▼ + stars: | 2023-10-06 | by ( Alex Harring | ) www.cnbc.com time to read: +1 min

Food and snack companies may feel the most pressure as weight-loss drugs become more mainstream and affect consumer behaviors, according to Bank of America. Diabetes drugs that mimic gut hormones such as glucagon-like peptide-1, or GLP-1, have found new audiences in people looking to lose weight. In some instances, people taking these medicines have reported less of a hankering for unhealthy foods or alcohol and other drinks. Weight-management products such as shakes or frozen meals could also be pressured, Meacham added. CNBC Pro compiled some of the stocks that could be at risk that the firm is watching.

Persons: Geoff Meacham, Meacham, —, Michael Bloom Organizations: Bank of America, Diabetes, CNBC Pro Locations: LSEG

(AP) — Abortion advocates asked a judge on Monday to rewrite what they call misleading descriptions of several constitutional amendments on abortion rights that voters could see on Missouri’s 2024 ballot. Missouri is among several states, including Ohio, where abortion opponents are fighting efforts to ensure or restore access to the procedure following the fall of Roe v. Wade last year. In Missouri, summaries of proposed constitutional amendments are provided on ballots to help voters understand what the measures would do. Ballot measures on abortion could also be put before voters in 2024 in states including Arizona, Maryland, New York and South Dakota. In all of them, including generally conservative Kansas and Kentucky, the abortion rights side prevailed.

Persons: Roe, Wade, State Jay Ashcroft, Tony Rothert, Jason Krol Lewis, Lewis, Rothert, Andrew Bailey, Scott, Fitzpatrick, Bailey, —, Geoff Mulvihill Organizations: JEFFERSON CITY, —, State, Supreme, Republican, Missouri Supreme, Associated Press Locations: Mo, Missouri, Ohio, U.S, Arizona , Maryland , New York, South Dakota, Oklahoma, Kansas, Kentucky, Cherry Hill , New Jersey

☆ Top Wall Street analysts select these dividend stocks to enhance returns
▼ + stars: | 2023-09-10 | by ( Tipranks.Com Staff | ) www.cnbc.com time to read: +7 min

To that effect, here are five attractive dividend stocks, according to Wall Street's top experts on TipRanks, a platform that ranks analysts based on their past performance. The analyst increased his price target for Verizon stock by $1 to $40, while maintaining AT&T's price target at $17. Also, he expects the prospects for improved free cash flow to lower net debt leverage and support the dividend payments. That said, with expectations of higher cash flow generation, Crum said that "the company should have more flexibility around growing its dividend going forward." (See Hasbro Stock Chart on TipRanks)Dell TechnologiesNext up is Dell (DELL), a maker of IT hardware and infrastructure technology, which rallied after its fiscal second-quarter results far exceeded Wall Street's estimates.

Persons: Hans Vestberg, Brendan McDermid, Wall, Michael Rollins, Rollins, MDT, Rick Wise, Geoff Martha, Wise, Drew Crum, Crum, TipRanks, Amit Daryanani, Daryanani, Dell Organizations: DELL, Verizon, New York Stock Exchange, Analysts, Verizon Communications, Citi, AT, Verizon Hedge, Hasbro, Dell Technologies, Dell, TipRanks, GPU, Walmart, &' $ Locations: New York, U.S

☆ Gilead Sciences could jump nearly 30% as biopharma bounces back, says Bank of America
▼ + stars: | 2023-09-08 | by ( Pia Singh | ) www.cnbc.com time to read: +2 min

The biopharmaceutical sector is poised to bounce back this year, and Gilead Sciences could be a key beneficiary, according to Bank of America. Analyst Geoff Meacham upgraded Gilead to buy from neutral. He increased his target price for the stock by $7 to $95, which suggests shares stand to gain 28.5% from where they closed Thursday. Shares of California-based Gilead have dropped 13.9% so far this year. "With the potential for broader interest in the sector, we are more optimistic on performance into 2H23," Meacham said.

Persons: Geoff Meacham, Meacham, biopharma, — Michael Bloom Organizations: Gilead Sciences, Bank of America, PrEP, Kite Pharma Locations: Gilead, California, HCV

Search resuls for: "Geoff M"

25 mentions found